Singapore General Hospital will NEVER ask you to transfer money over a call. If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg.

Help Us Improve Your Experience:

We’d love to hear from you! Rate the SGH website and share your feedback so we can enhance your online experience and serve you better. Click here to rate us

Clin Asst Prof Tan Hiang Keat

​MBBS (Spore), MRCP (UK)

Senior Consultant

Singapore General Hospital Singapore General Hospital

Specialty: Gastroenterology

Clinical Appointments

Academic Appointments

Clinical Assistant Professor, Duke-NUS Graduate Medical School

Clinical Senior Lecturer, Yong Loo Lin School of Medicine

Clinical Teacher, Lee Kong Chian School of Medicine

About

​Dr Tan Hiang Keat is a Senior Consultant with the Department of Gastroenterology & Hepatology. His subspecialties are Viral Hepatitis, Liver Cirrhosis and Portal Hypertension.

He is also a Clinical Tutor at the Yong Loo Lin Schoo of Medicine, National University of Singapore.

Education and Training

  • ​MBBS: NUS, 2003
  • MRCP: Edinburgh, 2007
  • Basic Specialist Training in Internal Medicine: Joint Committee of Specialist Training, Ministry of Health Singapore, 2007
  • Certificate of Specialist Accreditation (Gastroenterology): Specialist Accreditation Board, Ministry of Health Singapore, 2011

Awards

  • ​Best Registrar Award, SingHealth: 2011
  • Dean's List Award for Second Professional Examination (Part III), National University of Singapore: 2002
  • Dean's List Award for Second Professional Examination (Part I), National University of Singapore: 2000
  • Dean's List Award for First Professional Examination, National University of Singapore, 1999

Publications

Paper/Poster Presentations

  • Acute-on-Chronic Liver Failure in a Tertiary Centre in Singapore (Free paper), Asian Pacific Digestive Week, 2011
  • Role of the EUS in the Diagnosis and Management of Intermediate Pancreatic Cysts (Free paper), Digestive Disease Week, 2011 
  • EUS and Pancreatic Cysts Fluid Analysis in Predicting Potentially Malignant or Malignant Cystic Lesions of the Pancreas (Oral symposium), United European Gastroenterology Week, 2010

Research Projects

  • 2011: Identification of novel biomarkers to refine early HCC detection and to enable the molecular stratification of HCC patients for optimized personalized treatment (Co-investigator)
  • 2011: Prospective validation of transient elastography with XL probe for the evaluation of hepatic fibrosis in Asians with normal and elevated body mass index (Co-investigator)
  • 2010: Dose ranging study to evaluate the safety, efficacy of pegylated interferon lambda (BMS-914143) monotherapy in interferon naïve patients with chronic hepatitis B virus infection who are HBeAg-positive (Co-investigator II)
  • 2009: An open-label, randomized study to evaluate the acute immunologic responses in Asian subjects with E antigen positive Chronic Hepatitis B following initiation of therapy of Hepatitis B with Pegasys, Nucleoside analogues, or both (Co-investigator I)
  • 2009: An Open-label, Multi-center Protocol to observe the Effects of Pegylated Interferon Alfa-2a (PEGASYS ®) as Monotherapy in patients with Chronic Hepatitis B who have participated in Previous Roche or Roche Partner protocols (Co-investigator I)